Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.

Hideki Kawanishi1, Yoshindo Kawaguchi, Hiroyoshi Fukui

  • 1Tsuchiya General Hospital, Hiroshima, Japan. hidekawa@enjoy.ne.jp

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|September 24, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current status of assisted peritoneal dialysis in Japan: A nationwide questionnaire survey.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Initial Symptom Duration Among Vulnerable Dialysis Patients Hospitalized for Long-Term Care Correlates With Post-COVID-19 Poor Prognosis.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same author

Ultrasound-guided axillary brachial plexus block provides analgesia during percutaneous transluminal angioplasty for arteriovenous fistula or arteriovenous graft failures.

The journal of vascular access·2026
Same author

Injectable and transient hydrogel with programmable lifetime by endogenous coordination crosslinking and enzymatic de-crosslinking.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

SGLT2 gene polymorphism and cardio-renal outcomes.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Fabrication of a self-assembling peptide for the inhibition of cancer cell proliferation by targeting LAT1.

Chemical communications (Cambridge, England)·2026

Encapsulating peritoneal sclerosis (EPS), a serious complication of peritoneal dialysis (PD), occurred in 2.5% of patients over 4 years. Most cases were diagnosed after PD discontinuation, highlighting the need for caution with long-term PD use.

Area of Science:

  • Nephrology
  • Gastroenterology
  • Surgical Complications

Background:

  • Encapsulating peritoneal sclerosis (EPS) is a rare but severe complication associated with peritoneal dialysis (PD).
  • Understanding the incidence, clinical presentation, and outcomes of EPS is crucial for managing PD patients.

Purpose of the Study:

  • To determine the incidence of EPS in patients undergoing PD in Japan.
  • To investigate the clinical features and mortality rates associated with EPS.
  • To evaluate the impact of PD duration on EPS incidence and outcomes.

Main Methods:

  • A prospective, multicenter study involving 1,958 patients from 57 facilities in Japan.
  • Patients were followed for 4 years (April 1999 - March 2003) to observe EPS development.

Related Experiment Videos

  • Data collection included PD duration, diagnosis of EPS, treatment modalities, and patient outcomes.
  • Main Results:

    • The overall incidence of EPS was 2.5% (48 out of 1,958 patients).
    • EPS was diagnosed after PD discontinuation in 68.8% of affected patients.
    • Incidence and mortality rates of EPS increased significantly with longer PD duration, reaching 17.2% incidence and 100% mortality after 15 years.

    Conclusions:

    • The study established an EPS incidence of 2.5% over a 4-year period, with a significant proportion diagnosed post-PD cessation.
    • While PD appears safe for up to 8 years, extended use necessitates heightened vigilance due to increasing EPS risk.
    • Improved diagnostic and therapeutic strategies may allow continued PD with acceptable risk for shorter durations.